Tags » Axim

NetworkNewsBreaks – Medical Marijuana, Inc. (MJNA) Reports Positive Data on CanChew Plus® CBD Gum by AXIM® Biotechnologies, Inc. (AXIM)

Shares of Medical Marijuana (OTC: MJNA) are ticking higher after the company said its major investment company, AXIM® Biotechnologies (OTC: AXIM), received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials as treatment for irritable bowel syndrome (IBS). 477 more words

NetworkNewsWire Release

NetworkNewsBreaks – Medical Marijuana, Inc. (MJNA) Reports Positive Data on CanChew Plus® CBD Gum by AXIM® Biotechnologies, Inc. (AXIM)

Shares of Medical Marijuana (OTC: MJNA) are ticking higher after the company said its major investment company, AXIM® Biotechnologies (OTC: AXIM), received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials as treatment for irritable bowel syndrome (IBS). 477 more words

NetworkNewsWire Release

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on November 16, 2016

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: 280 more words

NetworkNewsWire Release

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on November 16, 2016

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: 280 more words

NetworkNewsWire Release

Medical Marijuana, Inc. Investment AXIM(R) Biotechnologies, Inc. Publishes Product Pipeline Chart for Pharma Clinical Trials Program

Cannabinoid Innovator s Product Pipeline Highlights Timelines of Its Intellectual Property (IP) Protected Cannabinoid-Based Products from Pre-Clinical to NDA for Multiple Indications SAN DIEGO, CA MJNA, (Marketwired November 03, 2016) Medical Marijuana, Inc. 50 more words

Medical Marijuana, Inc. Investment AXIM(R) Biotechnologies, Inc. Secures Funding to Continue Pharma Clinical Trials Program in Cannabinoid R&D

Financing Enables Cannabinoid Innovator to Continue Phase I-II Trials Of Numerous Intellectual Property (IP) Protected Cannabinoid-Based Products for Multiple Indications SAN DIEGO, CA AXIM, MJNA, (Marketwired October 26, 2016) Medical Marijuana, Inc. 50 more words

ARM Cortex-M7 Microcontroller

ARM has introduced a new processor of cortex M series, and this time it is Cortex M7. The ARM M7 processor is the most recent and highest performance member of the energy-efficient Cortex-M processor family. 723 more words

ARM Microcontroller